INTRODUCTION
Although urinary tract infections (UTI) occur in both men and women, clinical studies suggest that the overall prevalence of UTI is higher in women. Basic concepts related to the definition and diagnosis of UTI, associated risks of morbidity and mortality, and general treatment principles are reviewed in the introduction to the chapter on UTI in Women. This chapter addresses resource utilization, epidemiology, and costs of UTI in adult men.
DEFINITION AND DIAGNOSIS

Clinical
The clinical definitions of general UTI, including bacteriuria, cystitis, and pyelonephritis, are reviewed in the introduction to the chapter on UTI in women. As described above, male anatomic structures that may be involved with infectious processes include the prostate, testis, scrotum, and epididymis.
Analytic
Analyses presented in this chapter used ICD-9 diagnostic codes for UTI (Table 1 ). These codes are based primarily on the site and type of infection involved.
RISK FACTORS
Unlike the epidemiology of UTI in females, rates are much lower in young adults and rise dramatically in older men. Indeed, several potential risk factors for the development of UTI are unique to men. Bladder outlet obstruction due to benign prostatic hyperplasia (BPH) may be associated with urinary stasis. Even though a causal relationship has been difficult to prove, chronic prostatic obstruction is thought to increase the risk of UTI in older men with BPH. Instrumentation of the urinary tract may lead to iatrogenic UTI, either from cystoscopy or catheterization, both of which are common in the evaluation of men with obstructive voiding symptoms. UTI is an uncommon complication of transrectal prostate biopsy. Complications may range from acute prostatitis and cystitis to more complex infections, including pyelonephritis, osteomyelitis, and systemic urosepsis. The most common associated organisms are gastrointestinal flora, including anaerobes. Most clinicians utilize antimicrobial prophylaxis around the time of the procedure. Fluoroquinolones are particularly effective for this condition.
Bacterial prostatitis, which may be acute or chronic, is an uncommon clinical problem. Several forms of prostatitis are recognized in the National Institutes of Health (NIH) classification system (1) . Acute bacterial prostatitis (Type I) is characterized by rapid onset of symptoms, including fever and associated constitutional signs and symptoms. Urine cultures are typically positive, and intravenous antimicrobial therapy is often indicated. In contrast, chronic bacterial prostatitis (Type II) tends to be less pronounced in onset, with patients remaining asymptomatic between recurrent episodes. Recurrent cystitis is common. This is most likely due to persistence of pathogenic organisms in the prostatic
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Tomas L. Griebling, MD (Type III) , also known as chronic pelvic pain syndrome, is a condition characterized by chronic pelvic pain that is attributed to the prostate. Patients may also complain of obstructive and irritative urinary symptoms, sexual dysfunction, and penile, testicular, or groin pain. Chronic pelvic pain syndrome may be associated with increased concentrations of inflammatory cells in prostatic secretions, despite the absence of documentable bacterial infection.
The pathogenesis of prostatitis may be multifactorial. Reflux of infected urine into the prostatic ducts in the posterior urethra occurs in some patients, while ascending urethral infection plays a role in others. Hematogenous and lymphatic spread have also been hypothesized as possible causes. Reflux of noninfected urine may be associated with cases of nonbacterial prostatitis. It is hypothesized that this intraprostatic reflux of urine may lead to histochemical inflammatory changes in the absence of bacteria.
Prostatic abscess is a localized infection in the prostate. Patients at increased risk for development of prostatic abscesses include diabetics and men who are immunocompromised. Urethral instrumentation and chronic indwelling catheters may also increase risk. Historically, prostatic abscesses were caused by Neisseria gonorrhea. Today, however, most cases are associated with coliform organisms, Pseudomonas spp., and anaerobic organisms.
Urethritis and epididymitis are generally painful conditions caused by bacterial infection of the urethra and epididymis, respectively. Both disorders may be acute or chronic. These are considered separately in the chapter on sexually transmitted diseases (STDs).
Orchitis is often associated with bacterial epididymitis.
Isolated bacterial orchitis is less common. Mumps orchitis represents a specific form of the disease; it occurs in about 30% of mumps cases in postpubertal boys. The acute inflammation that occurs in these cases may lead to testicular atrophy and subsequent infertility. Other forms of orchitis include tuberculous orchitis, gangrenous orchitis, and testicular inflammation associated with infected hydroceles. In older men, most orchitis is probably related to bacterial UTI; however, in younger men, it usually represents a complication of sexually transmitted urethritis. These differences explain some of the demographic differences in hospitalization rates for orchitis noted later in this chapter. Orchitis is also addressed in the chapters on STDs and pediatric UTIs.
Scrotal infections may involve only the scrotal skin or may also include deeper structures. Fournier's gangrene is a severe form of scrotal infection associated with necrotizing fasciitis. Predisposing risk factors include diabetes, immunosuppression, poor perineal hygiene, and perirectal or perianal infections. Cultures typically yield mixed flora with both aerobic and anaerobic species. The risk of mortality with Fournier's gangrene is high because the infection can spread quickly along the layers of the abdominal wall that are contiguous with the scrotum. Aggressive surgical debridement and intravenous antimicrobial therapy are indicated.
PREVALENCE AND INCIDENCE
Approximately 20% of all UTIs occur in men. Between 1988 and 1994, the overall lifetime prevalence of UTI in men was estimated to be 13,689 cases per 100,000 adult men, based on the National Health and Nutrition Examination Survey (NHANES-III) (Tables  2 and 3 ). In comparison, the estimate for women was 53,067 cases per 100,000 adult women during the same time period (Chapter 6, Table 2 ).
Data from US Veterans Health Administration (VA) facilities supports the higher prevalence of UTI in women compared to men (Chapter 6, Figure  1 and Table 4 ). Between 1999 and 2001, the overall prevalence of UTI as a primary diagnosis in veterans seeking outpatient care was 2.3 to 2.48 times greater in women than it was in men. Rates of orchitis were generally higher than either cystitis or pyelonephritis when considered as either the primary or any diagnosis. Rates of UTI increased with age in this cohort and were higher in African American men than in other racial/ethnic groups (Table 4) . The VA data show that overall rates of outpatient visits associated with a primary diagnosis of UTI among adult male veterans dropped steadily between 1999 and 2001; this trend was most pronounced for older 1988-1994. men and occurred across all racial/ethnic groups and geographic regions.
TRENDS IN HEALTHCARE RESOURCE UTILIZATION
Antimicrobial therapy is the primary mode of treatment for most patients with UTI. Antimicrobial selection is tailored on the basis of culture and susceptibility data following the initiation of empiric therapy. Selection of antimicrobials is guided by the severity and location of the individual infection and by consideration of regional and local epidemiological data on bacterial resistance.
Healthcare providers treat patients with UTI in a variety of clinical settings. This section examines trends in treatment patterns for male UTI at different sites of service.
Inpatient Care
Inpatient care with administration of intravenous antimicrobials may be required to treat men with severe UTI. Increased patient age appears to be associated with an increased rate of inpatient treatment for UTI in men. Data from the Centers for Medicare and Medicaid Services (CMS) from 1992 to 1998 reveal that across all years of study, the rates of inpatient care for men 65 years of age and older are approximately 1.7 times those of men younger than 65 (Table 5 ). The younger group comprises primarily those who qualified for Medicare because of disability or end-stage renal disease. The risk appears to increase significantly with age; rates more than double in men aged 85 and older. For example, the rate of inpatient care in 1992 for men 85 to 94 years of age was 1,678 per 100,000 (95% CI, 1649-1706) compared with 777 per 100,000 (95% CI, 768-786) for men aged 75 to 84, and 308 per 100,000 (95% CI, 304-312) for men 65 to 74. This trend was similar in 1995 and 1998. Increased use of inpatient care may be associated with more severe infections in older men due to increased comorbidity and changes in immune response associated with increased age. In the time period covered by the Medicare data, rates of inpatient hospitalization for male UTI care were about 1.5 times higher in African Americans than in Caucasians or Hispanics (counts in Asians and North American Natives were too low to produce reliable estimates of rates). The rate of inpatient utilization was somewhat higher in the South than in other regions.
Data for 1994 to 2000 from the Healthcare Cost and Utilization Project (HCUP) reveal that the rates of inpatient hospital care for men with a primary diagnosis of UTI at any anatomic location have been relatively stable for young and middle-aged men (18 to 64 years) and for men between ages 65 and 74 (Table 6 ). In contrast, the rates of hospitalization for men in the 75-to 84-year age group have slowly declined, while the rates for men over 85 have gradually increased over time. The rates of inpatient care increase steadily with age, more than doubling with each decade beyond age 55. In this analysis, Asian men had the lowest rates of inpatient hospitalization for UTI care, followed by Hispanics and Caucasians. African American men had the highest rates of inpatient utilization. When analyzed by region, the lowest rates of inpatient care were seen in the West, while rates were similar in other geographic regions. Rates of inpatient care were similar in urban and rural settings. It is unclear why estimated inpatient utilization rates are lower in HCUP data than in CMS data. Data from HCUP also reveal that approximately 10% of all inpatient care for UTI in men is for the treatment of orchitis (Table 7) . Between 1994 and 2000, the overall rate of inpatient care for the treatment of orchitis was relatively stable, ranging from 12 to 14 per 100,000 population. Rates appear to rise gradually with age, the most significant increases occurring between 65 and 85 years of age. Inpatient utilization rates for elderly men decreased somewhat in 2000 compared to prior years. African American men had the highest rates of inpatient utilization for treatment of orchitis, and Asian men had the lowest rates. Inpatient utilization rates were slightly lower in the West than in other regions, and there was no significant difference between rates in urban and rural locations. The mean length of stay for inpatient hospitalizations in men with a primary diagnosis of UTI decreased from 6.5 days in 1994 to 5.1 days in 2000 (Table 8 ). Consistent with the general trend toward decreased use of inpatient care, this observation in men with UTI was noted across all age groups and , 1994, 1996, 1998, 2000. geographic regions, and in both rural and urban hospitals.
Outpatient Care
Outpatient care for UTI in men is administered in a variety of clinical settings, including hospital outpatient clinics, physician offices, ambulatory surgery centers, and emergency rooms. Each of these settings was analyzed separately.
Hospital Care
Data from the National Hospital Ambulatory Medical Care Survey (NHAMCS) from 1994 to 2000 reveal that hospital outpatient visits by men with UTI listed as any of the reasons for the visit have been variable (Table 9) , ranging from 91 to 175 per 100,000. When UTI was listed as the primary reason for the hospital patient visit, the rates increased from 80 per 100,000 (95% CI, 33-127) in 1996 to 136 per 100,000 (95% CI, 80-193) in 1998. The rate in 2000 dropped slightly, to 124 per 100,000 (95% CI, 62-186). These data suggest that there has been a general trend toward increased outpatient care for UTI in men. This complements the observed decreases in inpatient care noted above.
Hospital outpatient visit data from CMS reveal a similar increase in utilization during the past decade (Table 10 ). Among Medicare beneficiaries at least 65 years old, rates of hospital outpatient visits for men with UTI rose from 191 per 100,000 (95% CI, 189-194) in 1992 to 301 per 100,000 (95% CI, 298-304) in 1995, and 362 per 100,000 (95% CI, 358-365) in 1998. The most dramatic increases were observed in the oldest elderly men. In those 95 years of age and older, the rates of hospital outpatient visits more than doubled between 1992 and 1995 and doubled again between 1995 and 1998. Rates of hospital outpatient visits for UTI care in men were highest in the Midwest and South, and the rates in both regions have increased over time. In the years for which complete data regarding racial/ ethnic differences in outpatient hospital utilization were available (1995 and 1998), Hispanic men had the highest rates of utilization, followed by African American men. In 1998, the rates for Hispanic men were 1.23 and 1.80 times higher than those for African Americans and Caucasians, respectively (counts in Sample, 1994 Sample, , 1996 Sample, , 1998 Sample, , 2000 . Outpatient, 1994 Outpatient, , 1996 Outpatient, , 1998 Outpatient, , 2000 Asians were too low to produce reliable estimates of rates). The reason for this observed difference is unclear.
Physician Offices
The majority of UTIs in both men and women are treated in physicians' offices. According to data from the National Ambulatory Medical Care Survey (NAMCS), more than 1,896,000 physician office visits that included a diagnosis of UTI were made in 2000 by men in the United States (Table 11) . Of these visits, more than 1,290,000 were for a primary diagnosis of UTI. Fluctuations in rates of utilization have been observed over time, with peaks occurring in 1992 and 1996. In these years, the observed rates of physician office visits for UTI in men aged 55 and older were significantly higher than those for younger men. This likely reflects the higher incidence and prevalence of UTI in older men. The reasons for the dramatic increases in 1992 and 1996 are unclear but may be related to coding anomalies.
Medicare data for outpatient physician office visits for men with UTI indicate that rates of utilization remained relatively stable throughout the 1990s (Table  12) . Rates were consistently highest in men in the 85-to 94-year age group, followed by those aged 75 to 84 (Figure 2) . Rates in the most elderly cohort (95 and older) were similar to the overall mean. Regional variations in Medicare physician outpatient visits for men with UTI appear to have diminished over time and were least pronounced in 1998. As in the NHAMCS data, Hispanic men had the highest rates 1992, 1994, 1996, 1998, 2000 population estimates from Current Population Survey (CPS), CPS Utilities, Unicon Research Corporation, for relevant demographic categories of US male adult civilian non-institutionalized population. NOTE: Counts may not sum to totals due to rounding. SOURCE: National Ambulatory Medical Care Survey-Outpatient, 1992 , 1994 , 1996 , 2000 of physician office utilization among the racial/ethnic groups analyzed.
Ambulatory Surgery
Visits to ambulatory surgery centers represent a small percentage of Medicare visits for men with UTI (Table 13 ). Among Medicare beneficiaries at least 65 years old, rates ranged from 83 per 100,000 in 1992 (95% CI, 82-85) to 93 per 100,000 in 1995 (95% CI, 92-95) and 95 per 100,000 in 1998 (95% CI, 93-97). Rates were lower and more stable among younger Medicare beneficiaries who qualified because of disability or end-stage renal disease. As with Medicare physician office visits, the highest rates were observed in men 75 to 94 years of age. Rates were highest in the Midwest and Northeast and lowest in the South and West. The reasons for these geographic differences , 1992, 1995, 1998. are unclear. No clear racial/ethnic differences were observed in this analysis. The low rates of utilization for ambulatory surgery centers indicate that this is not a primary site of service for men with UTI. The cases identified likely represent perioperative UTI in men scheduled for outpatient surgery.
Emergency Room
Patients with UTI may present to an emergency room (ER) for initial evaluation and management. Data from NHAMCS indicate approximately 424,700 ER visits by men with a primary diagnosis of UTI in 2000 (Table 14 ). The overall rate of utilization in 2000 was 442 per 100,000, which is similar to the rate of 420 per 100,000 observed in 1994. Lower rates of ER utilization in this population were observed in 1996 and 1998. The rates of ER utilization by male Medicare -ER, 1994 -ER, , 1996 -ER, , 1998 -ER, , 2000 . beneficiaries were somewhat higher, ranging from 506 per 100,000 (95% CI, 502-510) in 1992 to 527 per 100,000 (95% CI, 523-531) in 1998 (Table 15) . In this analysis, utilization rates were consistently highest in the next-to-oldest cohort (85 to 94 years of age), followed closely by the oldest men (those 95 and older). Rates of ER utilization by older men were nearly twice those of men younger than 85 years of age. This may represent increased severity of infection in elderly men prompting evaluation in the ER. Rates of ER utilization in this cohort were consistently highest in the South. Again, the reason for the geographic variation is unclear. African American men had rates of ER utilization twice as high as those of Caucasians in this analysis (Figure 3 ). The lowest rates were observed in Asian men. Persons of other races, unknown race and ethnicity, and other region are included in the totals. NOTE: Counts less than 600 should be interpreted with caution. SOURCE: Centers for Medicare and Medicaid Services, 5% Carrier and Outpatient Files, 1992 Files, , 1995 Files, , 1998 
Nursing Homes
Information regarding UTI in men living in nursing home facilities was obtained from the National Nursing Home Survey of 1995 , 1997 ). The overall rates for men with either an admitting or current diagnosis of UTI in this sample appear stable over time, ranging from 5,642 per 100,000 in 1997 (95% CI, 4,641-6,642) to 5,803 per 100,000 in 1995 (95% CI, 4,794-6,812) . It is interesting to note that the rates of UTI for men living in nursing homes are closer to those for women than are the rates for the community-dwelling cohorts, as discussed in the chapter on UTI in Women (see Chapter 6 , . No clear trends were observed over time with regard to age in male nursing home residents. In all years studied, about half of male nursing home residents required special assistance using the toilet, regardless of whether they had a UTI (Table 18 ). In 1997, only 39% of men with UTI required special assistance using the toilet, but this survey item was skipped at a much higher rate that year, making its results difficult to interpret (Table 17) . Men with UTI had higher rates of incontinence than did the general cohort of male nursing home residents. It is not clear whether UTI or urinary incontinence is the causal factor.
The rates of indwelling catheter and ostomy use in male nursing home residents have remained stable at 11.9% in 1995 and 11.3% in 1999 (Table 18 ). This is of concern because of the well-established association between indwelling catheter use and urinary tract colonization and infection. Although these rates of catheter and ostomy use are not dramatic, they are higher than the 7.9 to 9.1% range observed in female nursing home residents. (see Chapter 6, Table 23 ).
ECONOMIC IMPACT
Direct Costs
Urinary tract infections in men are associated with a significant economic cost. Adjusted mean 24,404 5,803 (4,794-6,812) 25,063 5,642 (4,641-6,642) 26,229 5,743 (4,761-6,724) Age 18-74 8,223 5,746 (4,046-7,445) 9,158 6,011 (4,302-7,720) 9,552 5,860 (4,266-7,455) 75-84 8,017 5,554 (3,886-7,223) 7,082 4,408 (2,956-5,859) 9,438 6,311 (4,397-8,225) 85+ 8,164 6,135 (4,244-8,026) 8,822 6,723 (4,629-8,817) 7,239 5,020 (3,440-6,600) Race White 18,678 5,500 (4,403-6,597) 19,029 5,364 (4,258-6,470) 18,455 5,070 (4,052-6,087) Other 5,508 6,973 (4,453-9,493) 5,704 6,637 (4,252-9,021) 7,558 8,349 (5,608-11,089 ) a Rate per 100,000 male nursing home residents in the same demographic stratum. b Persons of unspecified race are included in the total. SOURCE: National Nursing Home Survey, 1995 Survey, , 1997 Survey, , 1999 . 
SOURCE:
Centers for Medicare and Medicaid Services, 5% Carrier and Outpatient Files, 1992 , 1995 6, 925 28, 375 (20, 546) 8, 960 357, 50 (26, 806) 6, 880 26, 229 (18, 680) No 17, 479 71, 625 (63, 796) 16, 103 64, 250 (55, 307) 19, 349 73, 771 (66, 221) Question left blank 12, 388 50, 761 (41, 830) 9, 869 39, 377 (30, 280) 14, 214 54, 192 (45, 092) No 4, 465 18, 295 (11, 297) 5, 885 23, 483 (15, 754) 4, 151 15, 828 (9, 312) Question skipped for allowed reason 7,329 30,032 (21,702-38,363) 9,068 36,183 (27,302-45,064) 7,513 28,643 (20,417-36,869) Question left ,337 (0-3,204) Requires assistance from equipment when using the toilet Yes 2, 546 10, 433 (4, 126) 2, 749 10, 970 (54, 452) 3, 038 11, 581 (5, 166) No 9, 629 39, 458 (30, 288) 6, 303 25, 149 (17, 954) 10, 352 39, 467 (30, 125) Question skipped for allowed reason 11,794 48,327 (39,262-57,392) 14,954 59,666 (50,709-68,623) 11,664 44,470 (35,581-53,360) Question left blank 435 1,782 (0-4,262) 1,056 4,215 (504-7,925) 1,176 4,482 (911-8,053) Requires assistance from another person when using the toilet Yes 12,388 50,761 (41,692-59,830) 9,637 38,450 (29,602-47,298) 14,214 54,192 (45,293-63,092 794 48,327 (39,262-57,392) 14,954 59,666 (50,709-68,623) 11,664 44,470 (35,581-53,360) Question left blank 223 912 (0-2,715) 472 1,884 (0-4,505) 351 1,337 (0-3,204) Has difficulty controlling urine (Table 19 ). In adults without a UTI, annual healthcare expenditures were lower for men than for women ($2,715 versus $3,833, respectively). However, there was little difference in total annual healthcare expenditures for men and women with UTI ($5,544 vs $5,407). The total annual estimated expenditures for outpatient prescription medication for the treatment of UTI in both men and women between 1996 and 1998 were estimated to exceed $96.4 million (Table  20) . Fluoroquinolones accounted for a large portion of these expenditures, in terms of both costs and numbers of claims. This may reflect a growing trend toward the use of fluoroquinolones rather than other types of antimicrobials for the treatment of UTI. The extent to which fluoroquinolones were prescribed as first-line therapy for prostatitis and other appropriate indications could not be determined from this dataset.
Indirect Costs
Overall time lost from work due to UTI was similar in men and women. Although men had only slightly higher rates of work loss due to cystitis (18% of men vs 16% of women), men tended to miss more than twice as much work time (10.5 hours vs 4.8 hours) (Table 21) . Men with pyelonephritis also missed more total time from work than did women (11.0 hours vs 7.7 hours), although the percentage of men missing work was slightly lower than the percentage of women (21% vs 24%). Of men diagnosed with orchitis in this sample, 14% reported missing work, for a mean total of 7.6 hours (95% CI, 2.3-12.9). For each ambulatory care visit or hospitalization for orchitis, men missed an average of 3.8 hours of work (95% CI, 1.2-6.5) (Table 22) .
Based on composite data, the overall medical expenditures for men with UTI in the United States were estimated to be approximately $1.028 billion in 2000 (Table 23 ). This is approximately 2.4 times lower than the overall amount spent to care for women with UTI during the same time period (see UTI in Women, Table 7 ). The costs of care for UTI in men appear to be increasing, as is the case with women (Table 23 and UTI in Women, Table 7 ). Inpatient care accounts for the largest portion of these expenditures, followed by physician office care and ER care. The total annual expenditures for male Medicare beneficiaries with UTI were approximately $480.2 million in 1998 (Table  24 ). This is significantly higher than the expenditures for younger male Medicare beneficiaries (total $91.1 million) but comparable on a per-person basis. Inpatient expenditures of older Medicare beneficiaries have remained constant over time after accounting for inflation (Table 25 ). However, spending on ambulatory services and emergency care has increased significantly in real terms between 1992 and 1998.
SPECIAL CONSIDERATIONS
Diabetes has been identified as a comorbid condition that may increase the risk of UTI. Some patients with diabetes develop voiding dysfunction, which predisposes them to an increased risk of UTI. Diabetes may also be associated with a component of immunosuppression. HCUP data from 1994 to 2000 indicate that the rates of diabetes as a comorbid condition in men hospitalized for UTI increased through the 1990s (Table 26 ). It is notable that diabetes is approximately twice as common among men hospitalized for UTI as it is in the general population (2). Orchitis 398 14% 1.5 (0.7-3.7) 6.1 (1.3-10.9) 7.6 (2.3-12.9) a Individuals with an inpatient or outpatient claim for a UTI and for whom absence data were collected. Work loss is based on reported absences contiguous to the admission and discharge dates of each hospitalization or the date of the outpatient visit. SOURCE: MarketScan, 1999. 
CONCLUSIONS
Urinary tract infections are among the most common urological disorders in both men and women. A variety of forms of UTI are recognized, and they may differ significantly, by location and severity. Overall, approximately 20% of all UTIs occur in men. These infections result in significant financial and personal costs for both individual patients and the healthcare system.
The data analyses presented here reveal several specific trends in men diagnosed with UTI. The overall rates of UTI in men appear to have remained stable during the 1990s. Although inpatient care still accounts for a significant portion of medical care for male UTI, there has been a general trend toward greater utilization of outpatient care in various settings for treatment of UTI-related disorders. Per capita financial expenditures for UTI in men appear similar to those for UTI in women. However, the mean time lost from work by men is somewhat greater. Hospital outpatient $2,800,000 (0.6%) $3,800,000 (0.8%) $4,700,000 (1.0%)
Ambulatory surgery $12,300,000 (2.8%) $17,400,000 (3.8%) $17,700,000 (3.7%)
Emergency room $16,800,000 (3.8%) $20,600,000 (4.5%) $22,400,000 (4.7%) NOTE: Percentages may not add to 100% because of rounding. SOURCE: Centers for Medicare and Medicaid Services, 1992 Services, , 1995 Services, , 1998 . 
